Alexander West
banner
craftycarbene.bsky.social
Alexander West
@craftycarbene.bsky.social
Chemoproteomics Scientist at EmpressTx
Harvard CCB alum from the Woo Lab
Reposted by Alexander West
“The prohibited activities would include joint research, co-authorship on papers, and advising a foreign graduate student or postdoctoral fellow. The language is retroactive, meaning any interactions during the previous 5 years could make a scientist ineligible for future federal funding.”
U.S. Congress considers sweeping ban on Chinese collaborations
Researchers speak out against proposal that would bar funding for U.S. scientists working with Chinese partners or training Chinese students
www.science.org
November 14, 2025 at 1:03 AM
Reposted by Alexander West
😍 Boston, you are beautiful. #NoKings
October 18, 2025 at 5:22 PM
Reposted by Alexander West
Today my @nytimes.com colleagues and I are launching a new series called Lost Science. We interview US scientists who can no longer discover something new about our world, thanks to this year‘s cuts. Here is my first interview with a scientist who studied bees and fires. Gift link: nyti.ms/3IWXbiE
nyti.ms
October 8, 2025 at 11:29 PM
Reposted by Alexander West
An mRNA Crime
www.science.org
August 6, 2025 at 5:53 PM
Reposted by Alexander West
RFK Jr and HHS just ended all US supported mRNA vaccine development
www.hhs.gov/press-room/h...
www.hhs.gov
August 6, 2025 at 12:49 AM
Reposted by Alexander West
Reposted by Alexander West
Excited to share a new preprint from the lab. We show that PTMs like phosphorylation & glycosylation dynamically reshape proteome-wide ligandability in cells, including proteins like KRAS. Great collaboration with the Huang Lab, @forlilab.bsky.social and BMS. www.biorxiv.org/content/10.1...
Post-Translational Modifications Remodel Proteome-Wide Ligandability
Post-translational modifications (PTMs) vastly expand the diversity of human proteome, dynamically reshaping protein activity, interactions, and localization in response to environmental, pharmacologi...
www.biorxiv.org
August 3, 2025 at 2:36 PM
Reposted by Alexander West
What, about 2 1/2 months?
Vinay Prasad: That Was Fast
www.science.org
July 30, 2025 at 8:42 PM
Reposted by Alexander West
Our paper outlining a new method for identifying selective protease substrates by phage display is finally out. Nice work from @mbarniolx.bsky.social. pubs.acs.org/doi/full/10....
pubs.acs.org
July 19, 2025 at 9:39 PM
Reposted by Alexander West
Summary Table of the massive defunding of biomedical research in the United States
www.nytimes.com/interactive/...
July 6, 2025 at 3:13 PM
Reposted by Alexander West
Reposted by Alexander West
I gave in! After students asking for it, I now made a simple figure design checklist.
To help all scientists w/o graphic skills create clear, accessible, and truthful charts!
-> Out in @nature Cell Biology: rdcu.be/erwl4

#DataVisualization #PhD #SciComm

Thx for review @bethcimini.bsky.social + 2
A checklist for designing and improving the visualization of scientific data
Nature Cell Biology - Creating clear and engaging scientific figures is crucial to communicate complex data. In this Comment, I condense principles from design, visual perception and data...
rdcu.be
June 18, 2025 at 8:33 AM
Reposted by Alexander West
The administration’s budget proposal is a disaster in so many ways, but it is most certainly a direct assault on US science.

Nothing like it has ever been seen before, and it means that we will have voluntarily stepped aside from a leading role in the scientific progress of the entire human race.
The Continuing Crisis, Part XV: The Horrendous Trump Budget
www.science.org
June 4, 2025 at 6:16 PM
Reposted by Alexander West
The gutting of US biomedical research with loss of ~2,500 grants affecting research for cancer, Alzheimer’s, infectious disease, global health and much more
www.nytimes.com/interactive/...
June 4, 2025 at 2:03 PM
I’m surprised Thermo would name their new Astral the “Zoom” when their whole company uses Microsoft Teams
June 2, 2025 at 2:40 PM
Reposted by Alexander West
New Preprint ... This was a bit different of a project than what we normally do for hardware comparisons. I think there is a lot of potential in the methods mentioned here for calibrating the instrument response to a common scale. Nice work by @chrhsu.bsky.social!

www.biorxiv.org/content/10.1...
Evaluation of an Orbitrap Astral Zoom mass spectrometer prototype for quantitative proteomics - beyond identification lists
Mass spectrometry instrumentation continues to evolve rapidly, yet quantifying these advances beyond conventional peptide and protein detections remains challenging. Here, we evaluate a modified Orbit...
www.biorxiv.org
June 1, 2025 at 4:47 AM
Reposted by Alexander West
I've pitched versions of this idea to a number of NIH scientists, as well as university researchers over the last six weeks or so. So I decided to put it together into a post.
May 17, 2025 at 9:13 PM
Reposted by Alexander West
www.nejm.org/doi/full/10....

"In this study, we describe a personalized base-editing therapy wholly developed in the 6-month span after a patient’s birth."
Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease | NEJM
Base editors can correct disease-causing genetic variants. After a neonate had received a diagnosis of severe carbamoyl-phosphate synthetase 1 deficiency, a disease with an estimated 50% mortality ...
www.nejm.org
May 16, 2025 at 1:09 AM
Reposted by Alexander West
Yesterday, the NIH R35 “Outstanding Investigator” grant to fund scientists in my lab studying antibiotic resistance was terminated for reasons not related to the content of the science, or any actions taken by me or members of my lab
May 13, 2025 at 11:37 PM
Reposted by Alexander West
Excited to share that our cell surface proteome review is now online on Chemical Reviews! 🥰 We highlight recent advances of techniques mapping cell surface protein expression, protein-protein interactions, extracellular PTMs and MHC complexes. @jimwellsucsf.bsky.social pubs.acs.org/doi/10.1021/...
Engineered Proteins and Chemical Tools to Probe the Cell Surface Proteome
The cell surface proteome, or surfaceome, is the hub for cells to interact and communicate with the outside world. Many disease-associated changes are hard-wired within the surfaceome, yet approved drugs target less than 50 cell surface proteins. In the past decade, the proteomics community has made significant strides in developing new technologies tailored for studying the surfaceome in all its complexity. In this review, we first dive into the unique characteristics and functions of the surfaceome, emphasizing the necessity for specialized labeling, enrichment, and proteomic approaches. An overview of surfaceomics methods is provided, detailing techniques to measure changes in protein expression and how this leads to novel target discovery. Next, we highlight advances in proximity labeling proteomics (PLP), showcasing how various enzymatic and photoaffinity proximity labeling techniques can map protein–protein interactions and membrane protein complexes on the cell surface. We then review the role of extracellular post-translational modifications, focusing on cell surface glycosylation, proteolytic remodeling, and the secretome. Finally, we discuss methods for identifying tumor-specific peptide MHC complexes and how they have shaped therapeutic development. This emerging field of neo-protein epitopes is constantly evolving, where targets are identified at the proteome level and encompass defined disease-associated PTMs, complexes, and dysregulated cellular and tissue locations. Given the functional importance of the surfaceome for biology and therapy, we view surfaceomics as a critical piece of this quest for neo-epitope target discovery.
pubs.acs.org
April 4, 2025 at 8:19 PM
Reposted by Alexander West
New preprint out co-led by Hannah Lloyd and Christina Woo at Harvard along with colleagues at the Broad and CeTPD Dundee gives insight on how to detect and discover native substrates of CRBN!
www.biorxiv.org/content/10.1...
A method for the detection and enrichment of endogenous cereblon substrates
C-Terminal cyclic imides are posttranslational modifications on proteins that are recognized and removed by the E3 ligase substrate adapter cereblon (CRBN). Despite the observation of these modificati...
www.biorxiv.org
April 3, 2025 at 8:35 PM
Reposted by Alexander West
🚀 Excited to share our latest article in #singlecell proteomics published in Cell!
We've developed SC-pSILAC to simultaneously measure protein turnover and abundance in single cells, unlocking the first large-scale, 2D proteomic insights at single-cell resolution!

www.cell.com/cell/fulltex...
Global analysis of protein turnover dynamics in single cells
The SC-pSILAC method enables single-cell measurement of both protein abundance and turnover, providing notable advances in the depth and versatility of proteomic technologies.
eur02.safelinks.protection.outlook.com
March 31, 2025 at 3:12 PM
Reposted by Alexander West
Congratulations Breanna Zerfas and teams at DFCI on this linkerless PROTAC degrading and ER-stress transmembrane protein IRE1α with CRBN!
pubs.rsc.org/en/content/a...
Structure-guided design of a truncated heterobivalent chemical probe degrader of IRE1α
IRE1α is an ER protein involved in the unfolded protein response (UPR) and dysregulation of the ER stress pathway has been implicated in several diseases. Inhibitors of the cytoplasmic endonuclease or...
pubs.rsc.org
March 20, 2025 at 5:58 PM
Reposted by Alexander West
Discovery of a cool new anti-fungal natural project with new #lipidtime mechanism!
March 19, 2025 at 5:11 PM
Reposted by Alexander West
It's finally in the Federal Register!

2 months late is better than never!
March 18, 2025 at 10:05 PM